Recent Reports


2010-02-08: Gold & Precious Metals, Base Metals and Non Metals Mining Report
7 leading Analysts; 4 Money Managers; and top management from 16 Sector Firms examine this vital industry in this 104 page report from The Wall Street Transcript.
More Information
Order this Report

2009-12-07: Oil & Gas Production and Distribution
8 leading Analysts; 2 Money Managers; and top management from 7 Sector Firms examine this vital industry in this 76 page report from The Wall Street Transcript.
More Information
Order this Report

09.21.09: Alternative Energy/Clean Energy/Power Generation/Utilities Report
1 roundtable, 7 analysts and 15 sector firms examine the energy and utilties segment in this 83 page report from The Wall Street Transcript.
More Information
Order this Report

Search TWST Online

TWST Newsletter

Give us your email address and receive the TWST Newsletter.


Company Interview Excerpt
RICHARD STEIBLIN - SYNGENTA AG (SYT) & (SYA.L)


Full article published: 01/29/2002


For Subscribers

Get this article online now!

Order just this article
TWST: Could we begin with an overview and historical sketch of Syngenta?
Mr. Steiblin: Syngenta is a new company that was created in November 2000 by the merger of Novartis Agribusiness and Zeneca Agrochemicals. As a result of this merger, Syngenta is the global number one in agribusiness, with pro forma sales in 2000 of 6.8 billion; 86% of these sales reside in crop protection, which is the industry name for agrochemicals, and 14% is in seeds.

TWST: Can you give us your assessment of the agribusiness space, the important trends and developments in progress?
We are, therefore, forming a new sector that is, in terms of how analysts would view it, somewhere between pharmaceuticals and chemicals. We have some of the characteristics of both, but we are neither pharmaceuticals nor specialty chemicals. The key differences with specialty chemicals are the importance of our R&D investment, the structure of our markets, and the fact that we have a future linked to advanced biological technologies. That makes us quite different.

 

Tickers included in this excerpt: SYA.L, SYT

 

For more information call (212) 952 7433. The Wall Street Transcript does not endorse any of the comments made by interviewees, and does not make stock recommendations.